The effect of intraoperative high-dose tranexanic acid on blood loss after operation for acute aortic dissection

被引:0
作者
Yoshiei Shimamura
Masamichi Nakajima
Toitsu Hirayama
Hironori Misumi
Tomohiro Shimokawa
Hideyuki Uesugi
Kazunori Uemura
机构
[1] Saiseikai Kumamoto Hospital,Department of Cardiovascular Surgery, Cardiovascular Center
来源
The Japanese Journal of Thoracic and Cardiovascular Surgery | 1998年 / 46卷 / 7期
关键词
Tranexamic Acid; Fibrinolytic Activity; Active Partial Thromboplastin Time; Reduce Blood Loss; Acute Aortic Dissection;
D O I
10.1007/BF03217790
中图分类号
学科分类号
摘要
The effect of high dose tranexamic acid on blood loss after operations for acute aortic dissection was evaluated. Twenty-eight patients undergoing emergent operations for acute aortic dissection were studied. There were two groups, group T with 13 patients (group T) who were given 7 g of tranexamic acid after induction of anesthesia and 3 g of it after CPB and group C with 15 patients who did not receive tranexamic acid. There was a tendency that group T had less bleeding during operation and after operation (559.6 ± 865.8 ml in group T and 805.8 ± 442.9 ml in group C, 1719.2 ± 1008.7 ml in group T and 3547.7 ± 4580.1 ml in group C, respectively), but there was no significant difference between two groups. The removal of drainage tubes after operation was significantly earlier in group T (5.0 ± 2.3 post operative day in group T and 8.1 ± 5.2 post operative day in group C; p<0.05). FDP and D-dimer level as measures of fibrinolytic activity were elevated at pre- and postoperative period in both groups, but they tended to be lower in group T at postoperative period. One patient required reexploration because of excessive bleeding and no mediastinal infection was reported in group T, whereas 4 patients underwent reexploration and 2 patients developed mediastinitis in group C. There were 5 hospital death (33.3%) in group C and 2 (15.4%) in group T. High dose of tranexamic acid seems to control fibrinolytic activity, thereby reducing blood loss and requirements, which may contribute to lower morbidity and mortality in operations for acute aortic dissection.
引用
收藏
页码:616 / 621
页数:5
相关论文
共 75 条
[1]  
Horrow JC(1990)Prophylactic tranexamic acid decreases bleeding after cardiac operations J Thorac Cardiovasc Surg 99 70-74
[2]  
Hlavacek J(1995)Prevention of bleeding after cardiopulmonary bypass with high-dose tranexamic acid, double blind, randomized clinical trial J Thorac Cardiovasc Surg 110 835-842
[3]  
Strong MD(1996)Tranexamic acid reduces postbypass blood use. A double-blinded, prospective, randomized study of 210 patients Ann Thorac Surg 61 1131-1135
[4]  
Collier W(1985)Hemostasis defects associated with cardiac surgery, prosthetic device, and other extracorporeal circuits Sem Thromb Hemost 11 249-280
[5]  
Brodsky I(1986)Increased fibrinolytic activity in patients undergoing cardiopulmonary bypass operation Am J Hematol 23 223-229
[6]  
Goldman SM(1962)Amino-methylcyclohexane-carboxylic acid. AMCHA A new potent inhibitor of the fibrinolysis Keio J Med 11 105-115
[7]  
Goel SM(1991)Effect of tranexamic acid on platelet ADP during extracorporeal circulation Am J Hematol 38 113-119
[8]  
Karski JM(1974)Pharmacokinetics of tranexamic acid after intravenous administration to normal volunteers Eur J Clin Pharmacol 7 375-380
[9]  
Teasdale SJ(1981)Pharmacokinetics and bioavailability of tranexamic acid Eur J Clin Pharmacol 20 65-72
[10]  
Norman P(1997)Additional postbypass administration of tranexamic acid reduces blood loss after cardiac operations J Thorac Cardiovasc Surg 113 802-804